Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates

Autor: B. Charmie Godornes, Nikhat Parveen, Lorenzo Giacani, Arturo Centurion-Lara, Austin M. Haynes, Mark C. Fernandez, Rui-Li Zhang
Jazyk: angličtina
Rok vydání: 2019
Předmět:
purl.org/pe-repo/ocde/ford#3.03.05 [https]
syphilis
TprK
Fluorescent Antibody Technique
Gene Expression
tp0897 gene
bacterial vaccine
Mass Spectrometry
immune response
disease burden
Epitopes
Mice
0302 clinical medicine
live vaccine
030212 general & internal medicine
Immunity
Cellular

Attenuated vaccine
Treponema
biology
quantitative analysis
Tp0435
Antibodies
Bacterial

Recombinant Proteins
Bacterial vaccine
Infectious Diseases
priority journal
Bacterial Vaccines
microscopy
Molecular Medicine
tprK gene
Rabbits
bacterial gene
purl.org/pe-repo/ocde/ford#1.06.03 [https]
030231 tropical medicine
animal experiment
Porins
Enzyme-Linked Immunosorbent Assay
purl.org/pe-repo/ocde/ford#3.03.08 [https]
immunization
Article
reverse transcription polymerase chain reaction
03 medical and health sciences
Antigen
Bacterial Proteins
Immunity
peptide vaccine
Animals
controlled study
Syphilis
Treponema pallidum
Borrelia burgdorferi
Antigens
Bacterial

nonhuman
General Veterinary
General Immunology and Microbiology
tp0435 gene
Public Health
Environmental and Occupational Health

biology.organism_classification
bacterial strain
Virology
Immunization
Peptide vaccine
gene expression
bacteria
New Zealand White (rabbit)
Peptides
Popis: Background Syphilis is resurgent in many developed countries and still prevalent in developing nations. Current and future control campaigns would benefit from the development of a vaccine, but although promising vaccine candidates were identified among the putative surface-exposed integral outer membrane proteins of the syphilis spirochete, immunization experiments in the rabbit model using recombinant antigens have failed to fully protect animals upon infectious challenge. We speculated that such recombinant immunogens, purified under denaturing conditions from Escherichia coli prior to immunization might not necessarily harbor their original structure, and hypothesized that enhanced protection would result from performing similar immunization/challenge experiments with native antigens. Methods To test our hypothesis, we engineered non-infectious Borrelia burgdorferi strains to express the tp0897 (tprK) and tp0435 genes of Treponema pallidum subsp. pallidum and immunized two groups of rabbits by injecting recombinant strains intramuscularly with no adjuvant. TprK is a putative integral outer membrane protein of the syphilis agent, while tp0435 encodes the highly immunogenic T. pallidum 17-kDa lipoprotein, a periplasmic antigen that was also shown on the pathogen surface. Following development of a specific host immune response to these antigens as the result of immunization, animals were challenged by intradermal inoculation of T. pallidum. Cutaneous lesion development was monitored and treponemal burden within lesions were assessed by dark-field microscopy and RT-qPCR, in comparison to control rabbits. Results Partial protection was observed in rabbits immunized with B. burgdorferi expressing TprK while immunity to Tp0435 was not protective. Analysis of the humoral response to TprK antigen suggested reactivity to conformational epitopes. Conclusions Immunization with native antigens might not be sufficient to obtain complete protection to infection. Nonetheless we showed that non-infectious B. burgdorferi can be an effective carrier to deliver and elicit a specific host response to T. pallidum antigens to assess the efficacy of syphilis vaccine candidates.
Databáze: OpenAIRE